| Parameter | AUC (95% CI) | P‐value |
|---|---|---|
| PCS (hPa) | 0.78 (0.62–0.89) | 0.0002 |
| TEG‐PM; MA‐ADP (mm) | 0.72 (0.55–0.85) | 0.0117 |
| TEG‐PM; %ADP‐Inhibition | 0.66 (0.49–0.80) | 0.0729 |
| VerifNow PRU | 0.58 (0.41–0.73) | 0.4166 |
| Parameter | AUC (95% CI) | P‐value |
|---|---|---|
| PCS (hPa) | 0.78 (0.62–0.89) | 0.0002 |
| TEG‐PM; MA‐ADP (mm) | 0.72 (0.55–0.85) | 0.0117 |
| TEG‐PM; %ADP‐Inhibition | 0.66 (0.49–0.80) | 0.0729 |
| VerifNow PRU | 0.58 (0.41–0.73) | 0.4166 |